CTLA4 and triple-A syndrome: Overexpression of CTLA4 in CTLA-4 transgenic Apoe-/- mice fed with WD and infused with Ang II limited AAA incidence by 66%, reduced the diameter of abdominal aorta and mortality by 26% (110).